Metagenomics Market

Metagenomics Market (Product Type: Instruments, Kits & Reagents, and Software & Services; and Technology: 16S Sequencing, Whole Genome Sequencing, Shotgun Sequencing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Metagenomics Market Outlook 2031

  • The global industry was valued at US$ 1.6 Bn in 2022
  • It is estimated to advance at a CAGR of 12.9% from 2023 to 2031 and reach US$ 4.6 Bn by the end of 2031

Analyst Viewpoint

Increase in research activities in microbiome studies and surge in prevalence of infectious diseases are boosting the metagenomics market size.

Metagenomics is one of the fastest-growing scientific disciplines and is helping identify novel pathogens and study zoonotic reservoirs to help predict and prevent outbreaks.

Emergence of COVID-19 pandemic is likely to offer lucrative metagenomics market opportunities to vendors. Microbiome profiling using shotgun metagenomic sequencing can be employed to identify unique microorganisms in COVID-19 patients.

Key players operating in the global metagenomics market are offering NGS-based, clinical metagenomics technology suites for clinical laboratories.

They are also providing versatile sequencing platforms suitable for a wide range of applications, including de novo sequencing and assembly of genomic DNA.

Market Introduction

Metagenomics is the study of the collective genomes of the members of a microbial community. Microorganisms constitute the majority of the Earth's biological diversity.

Metagenomics is the genomic analysis of microorganisms by direct extraction and cloning of DNA from their natural environment. It involves cloning and analyzing the genomes without culturing the organisms in the community.

Metagenomics in clinical diagnosis is helping evolve diagnosis and treatment approaches for infectious diseases. It is employed in in a wide range of areas including antimicrobial resistance, the microbiome, human host gene expression (transcriptomics), and oncology.

Metagenomics can facilitate function-based screenings for the discovery of novel proteins such as antibiotics. Rise in cases of drug resistance is expected to spur the metagenomics market growth in the near future as metagenomics is a promising tool for identifying and understanding antibiotic resistance mechanisms.

Attribute Detail
Drivers
  • Increase in Research Activities in Microbiome Studies
  • Surge in Prevalence of Infectious Diseases

Increase in Research Activities in Microbiome Studies Fueling Metagenomics Market Revenue

Microbiome studies focus on the collective genomes of microorganisms including bacteria, viruses, and fungi. These studies explore microorganisms inhabiting a particular environment such as the human body, soil, water, air, and various organisms.

Metagenomics is gaining traction in microbiome studies since it enables the analysis of all microorganisms, regardless of their ability to be cultured.

Metagenomics has wide applications in the fields of ecology & environment, drug discovery, clinical diagnostics, and food & beverages.

Major steps in metagenomic studies include sampling, sequencing, sequence read processing, assembly, gene prediction, binning, and functional annotation. Various types of metagenomic sequencing are used in metagenomics such as 165 sequencing, whole genome sequencing, and shotgun sequencing.

Rise in investment in microbiome research is propelling the metagenomics market demand. In October 2023, Leucine Rich Bio, an Indian microbiome company, raised an undisclosed amount in a pre-series A round of funding. The company intends to utilize funds for the development and marketing of new products.

Surge in Prevalence of Infectious Diseases Driving Market Progress

Clinical metagenomics is an emerging approach employed in the diagnosis of infectious diseases. It involves the use of Next-generation Sequencing (NGS) technology to identify the etiologic agents to allow for more effective and targeted treatment of infectious diseases.

Clinical metagenomics can be employed to study Central Nervous System (CNS) infections. It can also be used to explore Bone and Joint Infections (BJIs).

High prevalence of BJIs is boosting the metagenomics market dynamics. Approximately 20,000 cases of septic arthritis occur in the U.S. each year (7.8 cases per 100,000 person-years), with a similar incidence occurring in Europe. Septic arthritis is increasingly common among persons older than 65 years, among immunosuppressed individuals.

Future trends in metagenomics market technologies are offering access to previously unexplored volumes of sequence space from uncultured organisms. This, in turn, has opened up many new avenues of research, with the number of projects and potential applications of metagenomics expanding.

Metagenomics can help researchers analyze microbiome differences between individuals with severe or mild COVID-19. Metagenomics approaches can aid in exploring the gut microbiome in COVID-19 patients. This, in turn, is expected to help research in the fight against the SARS-CoV-2 infection.

Regional Outlook

Attribute Detail
Leading Region North America

According to the latest metagenomics market trends, North America held largest share in 2022. Technological advancements and high adoption rate of metagenomics sequencing are driving the market statistics in the region. The U.S. is investing in R&D activities to allow for improved responsiveness to disease outbreaks.

In January 2024, the U.K. announced a new Strategic Dialogue on Biological Security with the U.S. to protect from increased biological threats.

The partnership promotes responsible innovation in the biotechnology, health, and life sciences sectors to shape norms and standards on biosafety and biosecurity. Such initiatives are augmenting the metagenomics market share in North America as well as Europe.

Analysis of Key Players

Companies operating in the metagenomics market landscape are offering sample preparation automation for standardization and reliability. They are also providing an extensive range of microbiome solutions such as NGS, digital PCR (dPCR), and quantitative PCR (qPCR) to cater to various microbiome studies.

Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Arc Bio, LLC, Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., and Computomics GmbH are key players operating in the metagenomics industry.

Each of these companies has been profiled in the metagenomics market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.

Key Developments

  • In March 2024, Tiny Health, a manufacturer of at-home gut microbiome tests developed for babies, announced a US$ 8.5 Mn Series A round to further gut health innovation. The funding enables Tiny Health to continue R&D in the gut health testing category and avert the pediatric chronic conditions crisis.
  • In November 2023, QIAGEN launched the Microbiome WGS SeqSets, a comprehensive sample-to-insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research

Metagenomics Market Snapshot

Attribute Detail
Market Size in 2022 US$ 1.6 Bn
Market Forecast (Value) in 2031 US$ 4.6 Bn
Growth Rate (CAGR) 12.9%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • By Product Type
    • Instruments
    • Kits & Reagents
    • Software & Services
  • By Technology
    • 16S Sequencing
    • Whole Genome Sequencing
    • Shotgun Sequencing
    • Others
  • By Application
    • Ecology & Environment
    • Clinical Diagnostics
    • Drug Discovery
    • Biotechnology
    • Food & Beverages
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Illumina, Inc.
  • Promega Corporation
  • Novogene Co., Ltd.
  • Takara Bio Inc.
  • Oxford Nanopore Technologies plc
  • Arc Bio, LLC
  • Eurofins Scientific
  • Zymo Research
  • Microsynth AG
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Computomics GmbH
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global metagenomics market in 2022?

It was valued at US$ 1.6 Bn in 2022

How is the metagenomics business expected to grow by 2031?

It is anticipated to advance at a CAGR of 12.9% from 2023 to 2031

What are the key factors driving the demand for metagenomics?

Increase in research activities in microbiome studies and surge in prevalence of infectious diseases

Which region was the most lucrative in the metagenomics sector in 2022?

North America was the most lucrative region in 2022

Who are the prominent metagenomics vendors?

Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Arc Bio, LLC, Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., and Computomics GmbH

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Metagenomics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Metagenomics Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Metagenomics Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Instruments

            6.3.2. Kits & Reagents

            6.3.3. Software & Services

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Metagenomics Market Analysis and Forecast, by Technology

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Technology, 2017–2031

            7.3.1. 16S Sequencing

            7.3.2. Whole Genome Sequencing

            7.3.3. Shotgun Sequencing

            7.3.4. Others

        7.4. Market Attractiveness Analysis, by Technology

    8. Global Metagenomics Market Analysis and Forecast, by Application

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Application, 2017–2031

            8.3.1. Ecology & Environment

            8.3.2. Clinical Diagnostics

            8.3.3. Drug Discovery

            8.3.4. Biotechnology

            8.3.5. Food & Beverages

            8.3.6. Others

        8.4. Market Attractiveness Analysis, by Application

    9. Global Metagenomics Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Metagenomics Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product Type, 2017–2031

            10.3.1. Instruments

            10.3.2. Kits & Reagents

            10.3.3. Software & Services

        10.4. Market Value Forecast, by Technology, 2017–2031

            10.4.1. 16S Sequencing

            10.4.2. Whole Genome Sequencing

            10.4.3. Shotgun Sequencing

            10.4.4. Others

        10.5. Market Value Forecast, by Application, 2017–2031

            10.5.1. Ecology & Environment

            10.5.2. Clinical Diagnostics

            10.5.3. Drug Discovery

            10.5.4. Biotechnology

            10.5.5. Food & Beverages

            10.5.6. Others

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Product Type

            10.7.2. By Technology

            10.7.3. By Application

            10.7.4. By Country

    11. Europe Metagenomics Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product Type, 2017–2031

            11.3.1. Instruments

            11.3.2. Kits & Reagents

            11.3.3. Software & Services

        11.4. Market Value Forecast, by Technology, 2017–2031

            11.4.1. 16S Sequencing

            11.4.2. Whole Genome Sequencing

            11.4.3. Shotgun Sequencing

            11.4.4. Others

        11.5. Market Value Forecast, by Application, 2017–2031

            11.5.1. Ecology & Environment

            11.5.2. Clinical Diagnostics

            11.5.3. Drug Discovery

            11.5.4. Biotechnology

            11.5.5. Food & Beverages

            11.5.6. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Product Type

            11.7.2. By Technology

            11.7.3. By Application

            11.7.4. By Country/Sub-region

    12. Asia Pacific Metagenomics Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product Type, 2017–2031

            12.3.1. Instruments

            12.3.2. Kits & Reagents

            12.3.3. Software & Services

        12.4. Market Value Forecast, by Technology, 2017–2031

            12.4.1. 16S Sequencing

            12.4.2. Whole Genome Sequencing

            12.4.3. Shotgun Sequencing

            12.4.4. Others

        12.5. Market Value Forecast, by Application, 2017–2031

            12.5.1. Ecology & Environment

            12.5.2. Clinical Diagnostics

            12.5.3. Drug Discovery

            12.5.4. Biotechnology

            12.5.5. Food & Beverages

            12.5.6. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Product Type

            12.7.2. By Technology

            12.7.3. By Application

            12.7.4. By Country/Sub-region

    13. Latin America Metagenomics Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product Type, 2017–2031

            13.3.1. Instruments

            13.3.2. Kits & Reagents

            13.3.3. Software & Services

        13.4. Market Value Forecast, by Technology, 2017–2031

            13.4.1. 16S Sequencing

            13.4.2. Whole Genome Sequencing

            13.4.3. Shotgun Sequencing

            13.4.4. Others

        13.5. Market Value Forecast, by Application, 2017–2031

            13.5.1. Ecology & Environment

            13.5.2. Clinical Diagnostics

            13.5.3. Drug Discovery

            13.5.4. Biotechnology

            13.5.5. Food & Beverages

            13.5.6. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Product Type

            13.7.2. By Technology

            13.7.3. By Application

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Metagenomics Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Product Type, 2017–2031

            14.3.1. Instruments

            14.3.2. Kits & Reagents

            14.3.3. Software & Services

        14.4. Market Value Forecast, by Technology, 2017–2031

            14.4.1. 16S Sequencing

            14.4.2. Whole Genome Sequencing

            14.4.3. Shotgun Sequencing

            14.4.4. Others

        14.5. Market Value Forecast, by Application, 2017–2031

            14.5.1. Ecology & Environment

            14.5.2. Clinical Diagnostics

            14.5.3. Drug Discovery

            14.5.4. Biotechnology

            14.5.5. Food & Beverages

            14.5.6. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Product Type

            14.7.2. By Technology

            14.7.3. By Application

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Thermo Fisher Scientific, Inc.

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. QIAGEN

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Illumina, Inc.

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Promega Corporation

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Novogene Co., Ltd.

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Takara Bio Inc.

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Oxford Nanopore Technologies plc

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. Arc Bio, LLC

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. Eurofins Scientific

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

            15.3.10. Zymo Research

                15.3.10.1. Company Overview

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Financial Overview

                15.3.10.5. Strategic Overview

            15.3.11. Microsynth AG

                15.3.11.1. Company Overview

                15.3.11.2. Product Portfolio

                15.3.11.3. SWOT Analysis

                15.3.11.4. Financial Overview

                15.3.11.5. Strategic Overview

            15.3.12. F. Hoffmann-La Roche Ltd.

                15.3.12.1. Company Overview

                15.3.12.2. Product Portfolio

                15.3.12.3. SWOT Analysis

                15.3.12.4. Financial Overview

                15.3.12.5. Strategic Overview

            15.3.13. PerkinElmer, Inc.

                15.3.13.1. Company Overview

                15.3.13.2. Product Portfolio

                15.3.13.3. SWOT Analysis

                15.3.13.4. Financial Overview

                15.3.13.5. Strategic Overview

            15.3.14. Computomics GmbH

                15.3.14.1. Company Overview

                15.3.14.2. Product Portfolio

                15.3.14.3. SWOT Analysis

                15.3.14.4. Financial Overview

                15.3.14.5. Strategic Overview

    List of Tables

    Table 01: Global Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 03: Global Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 04: Global Metagenomics Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Metagenomics Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 07: North America Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 08: North America Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 09: Europe Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: Europe Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 12: Europe Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 13: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 15: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 16: Asia Pacific Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 20: Latin America Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 21: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 24: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    List of Figures

    Figure 01: Global Metagenomics Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Metagenomics Market Revenue (US$ Mn), by Product Type, 2022

    Figure 03: Global Metagenomics Market Value Share, by Product Type, 2022

    Figure 04: Global Metagenomics Market Revenue (US$ Mn), by Technology, 2022

    Figure 05: Global Metagenomics Market Value Share, by Technology, 2022

    Figure 06: Global Metagenomics Market Revenue (US$ Mn), by Application, 2022

    Figure 07: Global Metagenomics Market Value Share, by Application, 2022

    Figure 08: Global Metagenomics Market Value Share, by Region, 2022

    Figure 09: Global Metagenomics Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Metagenomics Market Value Share Analysis, by Product Type, 2022–2031

    Figure 11: Global Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2031

    Figure 12: Global Metagenomics Market Value Share Analysis, by Technology, 2022–2031

    Figure 13: Global Metagenomics Market Attractiveness Analysis, by Technology, 2020–2031

    Figure 14: Global Metagenomics Market Value Share Analysis, by Application, 2022–2031

    Figure 15: Global Metagenomics Market Attractiveness Analysis, by Application, 2020–2031

    Figure 16: Global Metagenomics Market Value Share Analysis, by Region, 2022–2031

    Figure 17: Global Metagenomics Market Attractiveness Analysis, by Region, 2020–2031

    Figure 18: North America Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Metagenomics Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Metagenomics Market Value Share Analysis, by Country, 2022–2031

    Figure 21: North America Metagenomics Market Value Share Analysis, by Product Type, 2022–2031

    Figure 22: North America Metagenomics Market Value Share Analysis, by Technology, 2022–2031

    Figure 23: North America Metagenomics Market Value Share Analysis, by Application, 2022–2031

    Figure 24: North America Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 25: North America Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 26: North America Metagenomics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 27: Europe Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 30: Europe Metagenomics Market Value Share Analysis, by Product Type, 2022–2031

    Figure 31: Europe Metagenomics Market Value Share Analysis, by Technology, 2022–2031

    Figure 32: Europe Metagenomics Market Value Share Analysis, by Application, 2022–2031

    Figure 33: Europe Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 34: Europe Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 35: Europe Metagenomics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 36: Asia Pacific Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 39: Asia Pacific Metagenomics Market Value Share Analysis, by Product Type, 2022–2031

    Figure 40: Asia Pacific Metagenomics Market Value Share Analysis, by Technology, 2022–2031

    Figure 41: Asia Pacific Metagenomics Market Value Share Analysis, by Application, 2022–2031

    Figure 42: Asia Pacific Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 43: Asia Pacific Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 44: Asia Pacific Metagenomics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 45: Latin America Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 48: Latin America Metagenomics Market Value Share Analysis, by Product Type, 2022–2031

    Figure 49: Latin America Metagenomics Market Value Share Analysis, by Technology, 2022–2031

    Figure 50: Latin America Metagenomics Market Value Share Analysis, by Application, 2022–2031

    Figure 51: Latin America Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 52: Latin America Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 53: Latin America Metagenomics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 54: Middle East & Africa Metagenomics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Metagenomics Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 57: Middle East & Africa Metagenomics Market Value Share Analysis, by Product Type, 2022–2031

    Figure 58: Middle East & Africa Metagenomics Market Value Share Analysis, by Technology, 2022–2031

    Figure 59: Middle East & Africa Metagenomics Market Value Share Analysis, by Application, 2022–2031

    Figure 60: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Product Type, 2023–2031

    Figure 61: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 62: Middle East & Africa Metagenomics Market Attractiveness Analysis, by Application, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved